Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR goggles calm nerves during heart angiography, study finds

NCT ID NCT07032935

Symptom relief Sponsor: Kutahya Health Sciences University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether wearing virtual reality (VR) glasses during coronary angiography can reduce anxiety and improve vital signs like heart rate and blood pressure. 84 patients were enrolled, and researchers measured anxiety levels before and after the procedure. The goal is to offer a safe, non-drug way to help patients relax during this common heart test.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality glasses
What this could lead to
If it works, this could offer a simple, drug-free way to help patients feel calmer and more comfortable during heart procedures like coronary angiography.
What could go wrong
This is a small, completed study with only 84 participants. The results may not apply to all patients or procedures, and the effect on actual medical outcomes is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

84 people

The number who actually took part.

Started

Jul 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients who will undergo coronary angiography or pacemaker implantation, Not to receive sedation during the procedure, Written and verbal acceptance to participate in the study, * Are over 18 years of age, * Do not have any psychiatric illness, * Do not have any vision, hearing or perception problems, * Are at least a primary school graduate, * Do not have any disorder/disease affecting decision-making ability (dementia, psychological disorder, etc.) * Volunteer to participate in the study, * Are open to communication and cooperation. Exclusion Criteria: * Patients who receive sedation, patients who cannot communicate, patients with visual or hearing impairments, and individuals who do not agree to participate in the research will be included.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary angiography (CAG) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary angiography (CAG)

Contacts and locations

Locations

  • Kutahya Health Sciences University

    Merkez, Kütahya, 43200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.